Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Parental perspectives on financial distress during treatment for childhood acute lymphoblastic leukemia: A qualitative report from Children's oncology group (COG) study ACCL20N1CD

Joanna Robles, Sheila Santacroce, Melissa Beauchemin, Yudy Muñeton-Castaño, Olivia Ponce, Lingyun Ji, Subhash Ramakrishnan, Kira Bona, Sarah Vargas, Crystal De Los Santos, Beth Fisher, Sarah Alexander, Lillian Sung, Susan Parsons

Blood (2025) 146 (Supplement 1): 2623.

https://doi.org/10.1182/blood-2025-2623

Published: 2025

Journal Articles

Blinatumomab mitigates the impact of traditional adverse prognosticators among children with standard risk b-acute lymphoblastic leukemia: Updated results of the Children's oncology group (COG) Trial AALL1731

Blood (2025) 146 (Supplement 1): 758.

https://doi.org/10.1182/blood-2025-758

Published: 2025

Journal Articles

Inadequate social support and household material hardship among children with pediatric acute lymphoblastic leukemia: A report from the Children's oncology group Trial AALL1731

Blood (2025) 146 (Supplement 1): 132.

https://doi.org/10.1182/blood-2025-132

Published: 2025

Journal Articles

National landscape of real-world pediatric blinatumomab care delivery in the United States: A report from the Children's Oncology Group

Blood (2025) 146 (Supplement 1): 1077.

https://doi.org/10.1182/blood-2025-1077

Published: 2025

Journal Articles

Severe toxicities in survivors of pediatric and adolescent acute lymphoblastic lymphoma: A population-based study in Ontario, Canada

Karen Arane, Cindy Lau, Qing Li, Paul Nathan, Sarah Alexander, Sumit Gupta

Blood (2025) 146 (Supplement 1): 3332.

https://doi.org/10.1182/blood-2025-3332

Published: 2025

Journal Articles

Feasibility of collecting social determinants of health data in the frontline pediatric acute lymphoblastic leukemia (ALL) trial AALL1731: A report from the Children's oncology group

Blood (2025) 146 (Supplement 1): 2742.

https://doi.org/10.1182/blood-2025-2742

Published: 2025

Journal Articles

Prior History of Severe Infection in Children, Adolescents and Young Adults with Lymphoma As Proxy for Inborn Errors of Immunity: Prevalence and Impact on Post-Lymphoma Outcomes

Aban Bahabri, Sarah Alexander, Cindy Lau, Sumit Gupta

Blood (2024) 144 (Supplement 1): 4470.

https://doi.org/10.1182/blood-2024-202290

Published: 2024

Journal Articles

A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma (Glo-BNHL)

Blood (2023) 142 (Supplement 1): 3097.

https://doi.org/10.1182/blood-2023-178658

Published: 2023

Journal Articles

A Potential Paradigm for the Robust and Systematic Prioritisation of Assets in Academic-Led, Multi-Industry Collaborative Trials in Rare Populations (Glo-BNHL)

Blood (2023) 142 (Supplement 1): 6247.

https://doi.org/10.1182/blood-2023-178724

Published: 2023

Journal Articles

The Impact of Cumulative Anesthesia Exposure on Neurocognitive Outcomes in Children with High-Risk Precursor B Acute Lymphoblastic Leukemia: A Multicenter Children's Oncology Group Study

Sarah Alexander, Sumit Gupta, John Kairalla, Emily Hibbitts, Hannah Weisman, Doralina Anghelescu, Naomi J Winick, Kevin R. Krull, Wanda L Salzer, Michael J. Burke, Lia Gore, Meenakshi Devidas, Stephen P. Hunger, Mignon L. Loh, Kristina Hardy

Blood (2022) 140 (Supplement 1): 2179–2180.

https://doi.org/10.1182/blood-2022-166765

Published: 2022

Journal Articles

Tisagenlecleucel Therapy Is Safe and Effective for Children with Down Syndrome with ALL in First Relapse

Joerg Krueger, Johann K Hitzler, Stephanie Audrey Mourad, Mylene Bassal, Elizabeth Cairney, Bruce N. Crooks, Angela Punnett, Sarah Alexander, Muhammad Ali, Henrique Bittencourt, James A. Whitlock, Sumit Gupta

Blood (2021) 138 (Supplement 1): 4820.

https://doi.org/10.1182/blood-2021-153262

Published: 2021

Journal Articles

A Phase 3 Randomized Trial of Inotuzumab Ozogamicin for Newly Diagnosed High-Risk B-ALL: Safety Phase Results from Children's Oncology Group Protocol AALL1732

Jennifer L. McNeer, Maureen M. O'Brien, Susan R. Rheingold, Meenakshi Devidas, Zhiguo Chen, Deepa Bhojwani, Anurag K. Agrawal, Brent Wood, Eugene Suh, Sarah Alexander, Tamara P. Miller, Olga Militano, Elizabeth A. Raetz, Mignon L. Loh

Blood (2021) 138 (Supplement 1): 3398.

https://doi.org/10.1182/blood-2021-149478

Published: 2021

Journal Articles

Brentuximab vedotin in combination with chemotherapy for pediatric patients with ALK + ALCL: results of COG trial ANHL12P1

Eric J. Lowe, Anne F. Reilly, Megan S. Lim, Thomas G. Gross, Lauren Saguilig, Donald A. Barkauskas, Rui Wu, Sarah Alexander, Catherine M. Bollard

Blood (2021) 137 (26): 3595–3603.

https://doi.org/10.1182/blood.2020009806

Published: 2021

Includes: Supplemental data

Journal Articles

Outcome Among Adolescents and Young Adults with Mature B-Cell Non Hodgkin Lymphoma at Pediatric Versus Adult Centers: A Population-Based Study Using the IMPACT Cohort

Sumit Gupta, MD, Nancy Baxter, MD PhD, Rinku Sutradhar, PhD, Sarah Alexander, MD, Jason Pole, PhD, Chenthila Nagamuthu, MPH, Paul Nathan, MD

Blood (2020) 136 (Supplement 1): 2–3.

https://doi.org/10.1182/blood-2020-136588

Published: 2020

Journal Articles

High Vs. Low-Intensity Bridging Chemotherapy in Children with Acute Lymphoblastic Leukemia Awaiting Chimeric Antigen Receptor T-Cell Therapy: A Population-Based Study from Ontario, Canada

Sumit Gupta, MD, Sarah Alexander, MD, Sue Zupanec, RN, Uma Athale, MDMBBS,MSc, Mylene Bassal, MD, Ethan Edwards, Paul J. Gibson, MD, Donna Johnston, MDFRCPC, Stacey Marjerrison, MD, Alexander Zorzi, MD, Johann K. Hitzler, MD, Ahmed Naqvi, MD, Angela Punnett, MD, James A. Whitlock, MD, Stephan A. Grupp, MD PhD, Shannon L. Maude, MD PhD, Joerg Krueger, MD

Blood (2018) 132 (Supplement 1): 1410.

https://doi.org/10.1182/blood-2018-99-115593

Published: 2018

Journal Articles

Image-Guided Therapy May Reduce the Risk of Traumatic or Failed Lumbar Punctures in Children with Acute Lymphoblastic Leukemia,

Furqan Shaikh, MD, Sarah Alexander, MD, Soumitra Tole, MSc, Laura Voicu, MSc, Lillian Sung, MD, PhD

Blood (2011) 118 (21): 3582.

https://doi.org/10.1182/blood.V118.21.3582.3582

Published: 2011

Journal Articles

Prophylactic Therapy with Fibrogammin Is Associated with a Decreased Incidence of Bleeding Episodes: A Retrospective Case Control Study.

Jeanne M. Lusher, MD, Steven W. Pipe, M.D., Sarah Alexander, M.D., Diane J. Nugent, M.D.

Blood (2006) 108 (11): 1014.

https://doi.org/10.1182/blood.V108.11.1014.1014

Published: 2006

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Parental perspectives on financial distress during treatment for childhood acute lymphoblastic leukemia: A qualitative report from Children's oncology group (COG) study ACCL20N1CD

Blinatumomab mitigates the impact of traditional adverse prognosticators among children with standard risk b-acute lymphoblastic leukemia: Updated results of the Children's oncology group (COG) Trial AALL1731

Inadequate social support and household material hardship among children with pediatric acute lymphoblastic leukemia: A report from the Children's oncology group Trial AALL1731

National landscape of real-world pediatric blinatumomab care delivery in the United States: A report from the Children's Oncology Group

Severe toxicities in survivors of pediatric and adolescent acute lymphoblastic lymphoma: A population-based study in Ontario, Canada

Feasibility of collecting social determinants of health data in the frontline pediatric acute lymphoblastic leukemia (ALL) trial AALL1731: A report from the Children's oncology group

Prior History of Severe Infection in Children, Adolescents and Young Adults with Lymphoma As Proxy for Inborn Errors of Immunity: Prevalence and Impact on Post-Lymphoma Outcomes

A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma (Glo-BNHL)

A Potential Paradigm for the Robust and Systematic Prioritisation of Assets in Academic-Led, Multi-Industry Collaborative Trials in Rare Populations (Glo-BNHL)

The Impact of Cumulative Anesthesia Exposure on Neurocognitive Outcomes in Children with High-Risk Precursor B Acute Lymphoblastic Leukemia: A Multicenter Children's Oncology Group Study

Tisagenlecleucel Therapy Is Safe and Effective for Children with Down Syndrome with ALL in First Relapse

A Phase 3 Randomized Trial of Inotuzumab Ozogamicin for Newly Diagnosed High-Risk B-ALL: Safety Phase Results from Children's Oncology Group Protocol AALL1732

Brentuximab vedotin in combination with chemotherapy for pediatric patients with ALK + ALCL: results of COG trial ANHL12P1

Outcome Among Adolescents and Young Adults with Mature B-Cell Non Hodgkin Lymphoma at Pediatric Versus Adult Centers: A Population-Based Study Using the IMPACT Cohort

High Vs. Low-Intensity Bridging Chemotherapy in Children with Acute Lymphoblastic Leukemia Awaiting Chimeric Antigen Receptor T-Cell Therapy: A Population-Based Study from Ontario, Canada

Image-Guided Therapy May Reduce the Risk of Traumatic or Failed Lumbar Punctures in Children with Acute Lymphoblastic Leukemia,

Prophylactic Therapy with Fibrogammin Is Associated with a Decreased Incidence of Bleeding Episodes: A Retrospective Case Control Study.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only